Enanta Pharmaceuticals
ENTA
ENTA
194 hedge funds and large institutions have $1.49B invested in Enanta Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 77 increasing their positions, 55 reducing their positions, and 26 closing their positions.
Holders
194
Holders Change
-1
Holders Change %
-0.51%
% of All Funds
4.22%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
28
Increased
77
Reduced
55
Closed
26
Calls
$4.51M
Puts
$12.2M
Net Calls
-$7.66M
Net Calls Change
-$5.29M
Top Buyers
Top Sellers
1 |
O
1
OrbiMed
New York
|
$0 |
2 |
MWNA
2
Marshall Wace North America
New York
|
$4.68M |
3 |
3
Invesco
Atlanta,
Georgia
|
$26.2M |
4 |
4
Renaissance Technologies
New York
|
$46.4M |
5 |
5
Millennium Management
New York
|
$5.51M |